22 EINSTEIN ST., 4TH FLOOR, NESS ZIONA, L3
BiomX Inc. Annual Meeting Results; Class II Directors Elected
Other Events
Reports Second Quarter 2025 Financial Results and Provides Program Updates
Shareholder Director Nominations
Corporate Presentation July 2025 Clinical Stage Programs Addressing Urgent Need for Overcoming Antibiotic Resistance
Reg. FD
Reports First Quarter 2025 Financial Results and Provides Business and Program Updates
Q2
Q1
FY 2024
Q3
Notice of Late Filing for Quarterly Report
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Notice of Suspension of Duty to File Reports
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
PRER14A
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership